Promis Neurosciences (Germany) Top Insiders

Promis Neurosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.8538) % which means that it has lost $0.8538 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.558) %, meaning that it generated substantial loss on money invested by shareholders. Promis Neurosciences' management efficiency ratios could be used to measure how well Promis Neurosciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Promis Neurosciences' Total Current Assets are most likely to increase significantly in the upcoming years. The Promis Neurosciences' current Intangible Assets is estimated to increase to about 44 K, while Other Current Assets are projected to decrease to roughly 30.3 K. The current Common Stock Shares Outstanding is estimated to decrease to about 1.1 M. The current Net Loss is estimated to decrease to about (11.1 M)Promis Neurosciences has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Some institutional investors establish a significant position in stocks such as Promis Neurosciences in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Promis Neurosciences, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Promis Neurosciences Workforce Comparison

Promis Neurosciences Benchmark Summation

Promis Neurosciences Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Promis Neurosciences often depends on how effective the management is. Promis Neurosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Promis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Promis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Promis Neurosciences' price analysis, check to measure Promis Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Promis Neurosciences is operating at the current time. Most of Promis Neurosciences' value examination focuses on studying past and present price action to predict the probability of Promis Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Promis Neurosciences' price. Additionally, you may evaluate how the addition of Promis Neurosciences to your portfolios can decrease your overall portfolio volatility.